当前位置：
X-MOL 学术
›
Cancer Genom. Proteom.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors.
Cancer Genomics & Proteomics ( IF 2.5 ) Pub Date : 2019-8-31 , DOI: 10.21873/cgp.20136 James Saller 1 , Shabnam Seydafkan 1 , Mohammad Shahid 1 , Manoj Gadara 1 , Mauro Cives 2 , Steven A Eschrich 3 , David Boulware 3 , Jonathan R Strosberg 2 , Nasir Aejaz 4 , Domenico Coppola 1, 5, 6, 7
Cancer Genomics & Proteomics ( IF 2.5 ) Pub Date : 2019-8-31 , DOI: 10.21873/cgp.20136 James Saller 1 , Shabnam Seydafkan 1 , Mohammad Shahid 1 , Manoj Gadara 1 , Mauro Cives 2 , Steven A Eschrich 3 , David Boulware 3 , Jonathan R Strosberg 2 , Nasir Aejaz 4 , Domenico Coppola 1, 5, 6, 7
Affiliation
Low-grade pancreatic neuroendocrine tumors (LG-PNETs) behave unpredictably. The aim of the study was to identify biomarkers that predict PNET metastasis to improve treatment selection.
中文翻译：
EPB41L5与低级胰腺神经内分泌肿瘤的转移潜能相关。
低度胰腺神经内分泌肿瘤（LG-PNETs）行为异常。该研究的目的是鉴定可预测PNET转移以改善治疗选择的生物标志物。
更新日期：2020-08-21
中文翻译：
EPB41L5与低级胰腺神经内分泌肿瘤的转移潜能相关。
低度胰腺神经内分泌肿瘤（LG-PNETs）行为异常。该研究的目的是鉴定可预测PNET转移以改善治疗选择的生物标志物。
京公网安备 11010802027423号